With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

New nano professor in Denmark

The Technical University of Denmark has appointed a recognized physicist as a new professor of miniaturized sensors.

Ny serie av svepelektronmikroskop från FEI

Den nya 50-serien av Quanta från FEI Company är familj svepelektronmikroskop som kan visa bilder av mjuka, icke-ledande prover och dynamiska processer.

Spinnkolonner utvecklade speciellt för ChIP

Isolering av DNA baserat på antikroppsinbindning till kromatin är ett effektivt verktyg för att studera det DNA som finns i närheten av de målproteiner som anti...

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

Sales Representative, Applied Biosystems

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

Novo och Astra ligger bra till i internationell kraftmätning

Patentutgångar kommer under de närmaste åren att drabba flera stora läkemedelsbolag, men Astrazeneca och Novo Nordisk hör till de som skymtar ljusglimtar enligt en analys.

Här är hela listan med de svenska ERC-miljonerna

Totalt har 236 forskare fått pengar från det europeiska forskningsrådet ERC. Tolv av dem kommer att arbeta med sina projekt i Sverige.

System för bildtagning anpassat för life science

Bildåtergivning. Gel logic 4000 pro är en helautomatiserad plattform för luminiscent, fluorescent, ultraviolett och radioisotop bildtagning som utvecklats speci...

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Welcome to wonderful Copenhagen

Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...

Ökade vårdkostnader i Europa kräver långsiktiga satsningar på innovation

Anna Nilsson Vindefjärd, Generalsekreterare på Forska Sverige.

Norwegian describes scrapie gene

Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...

Anything is measurable

At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into th...

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Diagnostics for personalized medicine

Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Changing e-solutions for clinical trials

Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...

Platform for high security virus purification

Millipore Corporation has introduced the Viresolve Pro Solution system, a new system for purification of viruses. The technology in the new platform includes a ...

Early stage research and low turnaround dominates

Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.